Annuncio • Apr 24
Era Co., Ltd., Annual General Meeting, May 14, 2026 Era Co., Ltd., Annual General Meeting, May 14, 2026, at 14:30 China Standard Time. Location: 4F, No. 555, Huangjiao Road, Huangyan District, Taizhou, Zhejiang China Annuncio • Mar 31
Era Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Era Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Annuncio • Dec 31
Era Co., Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Era Co., Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 Annuncio • Sep 30
Era Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Era Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annuncio • Jul 02
Era Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Era Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Annuncio • May 22
Era Co., Ltd. Approves Cash Dividend for the Year 2024 Era Co., Ltd. at the Annual General Meeting of 2024 held on 16 May 2025, approved cash dividend/10 shares (tax included) of CNY 0.50000000 for the year 2024. Annuncio • Apr 25
Era Co., Ltd. Proposes Final Cash Dividend for 2024 Era Co., Ltd. proposed final cash dividend of CNY 0.50000000 per 10 shares (tax included) for 2024. Annuncio • Apr 24
Era Co., Ltd., Annual General Meeting, May 16, 2025 Era Co., Ltd., Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: 4F, No. 555, Huangjiao Road, Huangyan District, Taizhou, Zhejiang China Annuncio • Mar 31
Era Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Era Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Annuncio • Dec 31
Era Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 Era Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025 Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.019 (vs CN¥0.092 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.019 (down from CN¥0.092 in 3Q 2023). Revenue: CN¥1.62b (down 14% from 3Q 2023). Net income: CN¥22.4m (down 79% from 3Q 2023). Profit margin: 1.4% (down from 5.7% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥4.56, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 1.9% over the past three years. Annuncio • Sep 30
Era Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Era Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Annuncio • Jun 29
Era Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Era Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Annuncio • Apr 28
Era Co., Ltd., Annual General Meeting, May 17, 2024 Era Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Taizhou, Zhejiang China Agenda: To consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual report and its summary; to consider 2023 annual accounts report; to consider 2024 estimated guarantee for controlled subsidiaries and guarantee among controlled subsidiaries; to consider 2023 profit distribution plan; to consider reappointment of 2024 audit firm; and to consider other matters. Annuncio • Apr 27
Era Co., Ltd. Announces Profit Distribution Proposal of Final Cash Dividend for the Year 2023 Era Co., Ltd. announced on 26 April 2024 the profit distribution proposal of final cash dividend per ten shares (tax included) of CNY 1.00000000 for the year 2023. Reported Earnings • Apr 26
Full year 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.066 in FY 2022) Full year 2023 results: EPS: CN¥0.30 (up from CN¥0.066 in FY 2022). Revenue: CN¥7.47b (down 6.4% from FY 2022). Net income: CN¥362.9m (up 346% from FY 2022). Profit margin: 4.9% (up from 1.0% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Annuncio • Mar 30
Era Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Era Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.066 in FY 2022) Full year 2023 results: EPS: CN¥0.32 (up from CN¥0.066 in FY 2022). Revenue: CN¥7.48b (down 6.3% from FY 2022). Net income: CN¥394.3m (up 385% from FY 2022). Profit margin: 5.3% (up from 1.0% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥4.39, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years. Valuation Update With 7 Day Price Move • Jan 10
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥5.91, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 4.1% over the past three years. Annuncio • Dec 29
Era Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Era Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.092 (vs CN¥0.002 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.092 (up from CN¥0.002 in 3Q 2022). Revenue: CN¥1.88b (down 10% from 3Q 2022). Net income: CN¥107.7m (up CN¥105.6m from 3Q 2022). Profit margin: 5.7% (up from 0.1% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. New Risk • Aug 29
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.4% net profit margin). Reported Earnings • Aug 24
Second quarter 2023 earnings released: EPS: CN¥0.081 (vs CN¥0.022 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.081 (up from CN¥0.022 in 2Q 2022). Revenue: CN¥2.05b (flat on 2Q 2022). Net income: CN¥93.7m (up 202% from 2Q 2022). Profit margin: 4.6% (up from 1.5% in 2Q 2022). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Annuncio • Aug 10
Era Co., Ltd. Announces Executive Appointments Era Co., Ltd. at the Extraordinary General Meeting of 2023 on 08 August 2023, approved Election of non-independent directors, cumulative voting system applicable: Zhang Yichen; Election of independent directors, cumulative voting system applicable: Yi Jianhui; Election of non-employee supervisors, cumulative voting system applicable: Chen Wei. Annuncio • May 25
Era Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023 Era Co., Ltd. announced cash dividend of CNY 0.12000000 per 10 shares (tax included) on A shares for the year 2022. Record date is 30 May 2023, Ex-date is 31 May 2023 and Payment date is 31 May 2023. Reported Earnings • Apr 23
First quarter 2023 earnings released: EPS: CN¥0.06 (vs CN¥0.03 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.06 (up from CN¥0.03 in 1Q 2022). Revenue: CN¥1.60b (down 6.7% from 1Q 2022). Net income: CN¥76.8m (up 139% from 1Q 2022). Profit margin: 4.8% (up from 1.9% in 1Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.002 (vs CN¥0.09 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.002 (down from CN¥0.09 in 3Q 2021). Revenue: CN¥2.10b (down 13% from 3Q 2021). Net income: CN¥2.19m (down 98% from 3Q 2021). Profit margin: 0.1% (down from 4.4% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Oct 12
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥5.34, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 16% over the past year. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥5.39, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 11% over the past year. Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥5.61, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 17x in the Chemicals industry in China. Total loss to shareholders of 10% over the past year. Reported Earnings • Apr 30
First quarter 2022 earnings released: EPS: CN¥0.03 (vs CN¥0.06 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.03 (down from CN¥0.06 in 1Q 2021). Revenue: CN¥1.71b (up 8.1% from 1Q 2021). Net income: CN¥32.2m (down 57% from 1Q 2021). Profit margin: 1.9% (down from 4.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 19%, compared to a 43% growth forecast for the industry in China. Reported Earnings • Apr 13
Full year 2021 earnings released: EPS: CN¥0.47 (vs CN¥0.68 in FY 2020) Full year 2021 results: EPS: CN¥0.47 (down from CN¥0.68 in FY 2020). Revenue: CN¥8.88b (up 26% from FY 2020). Net income: CN¥576.9m (down 25% from FY 2020). Profit margin: 6.5% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 20%, compared to a 48% growth forecast for the industry in China. Reported Earnings • Mar 04
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: CN¥0.48 (down from CN¥0.68 in FY 2020). Revenue: CN¥8.88b (up 26% from FY 2020). Net income: CN¥593.8m (down 23% from FY 2020). Profit margin: 6.7% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.9%. Over the next year, revenue is forecast to grow 20%, compared to a 48% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Jan 26
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥5.30, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 10% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥2.71 per share. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥6.38, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 2.2% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥2.71 per share. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.23 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥2.42b (up 24% from 3Q 2020). Net income: CN¥107.7m (down 59% from 3Q 2020). Profit margin: 4.4% (down from 13% in 3Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.24 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥2.37b (up 21% from 2Q 2020). Net income: CN¥177.3m (down 26% from 2Q 2020). Profit margin: 7.5% (down from 12% in 2Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Jul 21
Second quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.24 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥2.37b (up 21% from 2Q 2020). Net income: CN¥177.3m (down 26% from 2Q 2020). Profit margin: 7.5% (down from 12% in 2Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Apr 28
First quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.03 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.58b (up 87% from 1Q 2020). Net income: CN¥75.1m (up 98% from 1Q 2020). Profit margin: 4.7% (up from 4.5% in 1Q 2020). The increase in margin was driven by higher revenue. Is New 90 Day High Low • Jan 26
New 90-day low: CN¥6.05 The company is down 18% from its price of CN¥7.38 on 29 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥14.39 per share. Analyst Estimate Surprise Post Earnings • Jan 26
Revenue misses expectations Revenue missed analyst estimates by 0.8%. Over the next year, revenue is forecast to grow 18%, compared to a 50% growth forecast for the Chemicals industry in China. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥6.14 The company is down 26% from its price of CN¥8.30 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.20 per share. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥6.96 The company is down 14% from its price of CN¥8.14 on 18 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥20.46 per share. Is New 90 Day High Low • Dec 01
New 90-day low: CN¥7.01 The company is down 22% from its price of CN¥9.04 on 02 September 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥17.82 per share. Is New 90 Day High Low • Oct 29
New 90-day low: CN¥7.38 The company is down 15% from its price of CN¥8.68 on 31 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥19.32 per share. Reported Earnings • Oct 20
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥724.2m, up 76% from the prior year. Total revenue was CN¥6.64b over the last 12 months, up 9.8% from the prior year. Valuation Update With 7 Day Price Move • Oct 12
Market bids up stock over the past week After last week's 16% share price gain to CN¥8.82, the stock is trading at a trailing P/E ratio of 16.9x, up from the previous P/E ratio of 14.6x. This compares to an average P/E of 39x in the Chemicals industry in China.